Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala 2 GIP in rat model of Huntington's disease-Reference-Cited by-同舟云学术

Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala 2 GIP in rat model of Huntington's disease

Published:2018-06 Issue: Volume:828 Page:31-41
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Verma Mahip K.,Goel Rajan,Nandakumar Krishnadas,Nemmani Kumar V.S.

Funder

Lupin Limited

Publisher

Elsevier BV

Subject

Pharmacology

Reference65 articles.

1. Huntington's Disease;Bates,2002

2. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease;Beal;J. Neurosci.,1991

3. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid;Beal;Nature,1986

4. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea;Bedard;Park. Relat. Disord.,2011

5. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl;Behan;Br. J. Pharmacol.,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases;Frontiers in Cellular Neuroscience;2024-03-07

2. Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1;Nature Reviews Endocrinology;2022-12-12

3. The role of ferroptosis in neurodegenerative diseases;Molecular Biology Reports;2022-11-16

4. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway;European Journal of Pharmacology;2022-11

5. Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies;Neuropharmacology;2022-09